论文部分内容阅读
目的探讨淋巴细胞主动免疫在复发性流产(RSA)治疗中的应用价值。方法选取接受治疗的80例封闭抗体缺乏所致RSA患者随机分为对照组36例给予传统保胎治疗,观察组44例给予淋巴细胞主动免疫治疗,比较两组妊娠结局及血液流变学指标变化情况。另选取同期体检的80例正常妊娠孕妇为正常妊娠组,比较RSA患者与正常妊娠孕妇血液流变学指标。结果RSA组患者全血黏度中高切、低切及血浆黏度均明显高于正常妊娠组,差异有统计学意义(P<0.05);观察组妊娠成功率84.1%,对照组47.2%,两组差异有统计学意义(P<0.05)。观察组44例患者中,36例封闭抗体阳性患者妊娠的成功率为91.7%,8例封闭抗体阴性患者妊娠成功率为50.0%,两者差异有统计学意义(P<0.05)。经治疗,观察组血液流变学指标恢复正常比例显著高于对照组,差异有统计学意义(P<0.05)。结论 RSA患者血液黏度明显增高,采用淋巴细胞主动免疫治疗可对患者妊娠结局及血液流变学予以有效改善,值得推广。
Objective To investigate the value of active immunization of lymphocytes in the treatment of recurrent spontaneous abortion (RSA). Methods A total of 80 patients with RSA induced by lack of block antibody were randomly divided into control group (36 cases) given traditional tocolytic therapy and observation group (44 cases) received active lymphocyte immunotherapy. The pregnancy outcome and hemorheological indexes were compared between the two groups Happening. In addition, 80 normal pregnant women in the same period of physical examinations were selected as the normal pregnancy group, and the hemorheological parameters of RSA patients and normal pregnant women were compared. Results In the RSA group, the whole blood viscosity of the whole blood was significantly higher than that of the normal pregnancy group (P <0.05). The pregnancy success rate was 84.1% in the observation group and 47.2% in the control group. There was significant difference between the two groups There was statistical significance (P <0.05). Among the 44 patients in the observation group, the success rate of pregnancy in 36 patients with positive antibody was 91.7%, and that in 8 patients with negative antibody was 50.0%. The difference was statistically significant (P <0.05). After treatment, the observation group hemorheology index returned to normal proportion was significantly higher than the control group, the difference was statistically significant (P <0.05). Conclusion The blood viscosity of patients with RSA is significantly increased. The active immunotherapy with lymphocytes can effectively improve the pregnancy outcome and hemorheology in patients with RSA, which deserves promotion.